· Original article
Glass House production hits record as Q3 margins narrow
Glass House production reached 317,000 pounds in Q3 2026, but lower selling prices squeezed margins. Management reaffirmed its annual output forecast.
FINANCEVELIX / News
Equities & companies · Page 265
Equities & companies
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
My news topics
My news topics →Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 4,014 · Page 265 / 335
· Original article
Chord Energy CEO Michael Lou Takes Over as Danny Brown Exits
Chord Energy CEO Michael Lou took office on October 19, 2026, replacing Danny Brown. The filing details the board change and compensation arrangements.
· Original article
Nasdaq futures rise 1.3% ahead of possible Wall Street rebound
Nasdaq futures rose 1.3% before the October 19 open after a technology selloff, while U.S. crude eased but remained above $100 a barrel.
· Original article
Westerman acquisition gives Centrus control of key supplier
Centrus completed its $116 million Westerman acquisition, bringing centrifuge-component manufacturing in-house and adding non-nuclear industrial customers.
· Original article
Globe Life shares jump 8.53% before October 21 earnings
Globe Life shares rose 8.53% before the October 19, 2026 market open, ahead of third-quarter results scheduled for October 21 after the close.
· Original article
Centrus acquisition brings Westerman in-house for $116 million
The $116 million Centrus acquisition of Westerman brings a centrifuge supplier in-house and adds industrial manufacturing customers beyond nuclear fuel.
· Original article
Silgan Trivium deal targets $3.4 billion cash acquisition
The Silgan Trivium deal proposes a $3.4 billion cash acquisition, with closing expected in mid-2027 and earnings benefits still forecasts.
· Original article
EyePoint restructuring targets DME after Phase 3 setback
EyePoint restructuring plans include a roughly 53% workforce cut and a shift toward DME trials after Duravyu missed a pivotal wet AMD endpoint.
· Original article
Jyske Bank acquisition of Formuepleje wins Danish approval
Jyske Bank acquisition of Formuepleje has received Danish competition approval, with completion expected to take effect on November 2, 2026.
· Original article
Glass House costs to hold steady in Q4 as pricing weighs
Glass House costs are expected to hold near $110 per pound in Q4 2026, while lower selling prices pressure margins despite record preliminary revenue.
· Original article
Werner earnings preview shows cost pressure; shares fall 4.3%
Werner earnings estimates for Q3 2026 reflect $0.18 a share in cost headwinds. Shares fell 4.3% pre-market ahead of the October 27 results release.
· Original article
Helix catheter FDA pre-submission accepted, BioCardia says
BioCardia says the FDA accepted its revised Helix catheter pre-submission, with written feedback and a meeting expected in the fourth quarter of 2026.
Charts and market data by TradingView. Availability and delays vary by exchange.